Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Gerald B. Appel
ResearcherPublications, citations & collaboration network
Gerald B. Appel is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 347 works, 32,008 citations, an h-index of 89 and an i10-index of 223.
347
Works
32,008
Citations
89
h-index
223
i10-index
IDs:OpenAlex
How has Gerald B. Appel's publication output changed over time?
ScholarIQpublication output · 2004–2019
Output declined67% over the shown period — from 3 works in 2004 to 1 in 2019.
3
1
1
1
1
1
1
1
1
1
2004200520092011201220132014201620182019
What are the most-cited papers on Gerald B. Appel?
ScholarIQmost cited works
The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited
Jan J. Weening, Vivette D. D’Agati, Melvin M. Schwartz, Surya V. Seshan, Charles E. Alpers, Gerald B. Appel, James E. Balow, Jan A. Bruijn, Terence Cook, Franco Ferrario, Agnes B. Fogo, Ellen M. Ginzler, Lee A. Hebert, Gary S. Hill, Prue Hill, J. Charles Jennette, Norella Kong, Philippe Lesavre, Michael D. Lockshin, Lai‐Meng Looi, Hirofumi Makino, Luiz A. Moura, Michio Nagata
Journal of the American Society of Nephrology. 20042,006 CitationsOPEN ACCESS
The classification of glomerulonephritis in systemic lupus erythematosus revisited
Jan J. Weening, ON Behalf of the International Society of Nephrology and Renal Pathology Society Working Group on the Classification Oflupus Nephritis, Vivette D. D’Agati, Melvin M. Schwartz, Surya V. Seshan, Charles E. Alpers, Gerald B. Appel, James E. Balow, Jan A. Bruijn, Terence Cook, Franco Ferrario, Agnes B. Fogo, Ellen M. Ginzler, L Hebert, Gary S. Hill, Prue Hill, J. Charles Jennette, Norella Kong, Philippe Lesavre, Michael D. Lockshin, Lai‐Meng Looi, Hirofumi Makino, Luiz A. Moura, Michio Nagata
Kidney International. 20041,665 CitationsOPEN ACCESS
Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
Brad H. Rovin, Richard Furie, Kevin Latinis, R. John Looney, Fernando C. Fervenza, Jorge Sánchez‐Guerrero, Romeo Maciuca, David Zhang, Jay Garg, Paul Brunetta, Gerald B. Appel, LUNAR Investigator Group
S132787887. 20121,454 Citations
Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis
Ellen M. Ginzler, Mary Anne Dooley, Cynthia Aranow, Mimi Kim, Jill P. Buyon, Joan T. Merrill, Michelle Petri, Gary S. Gilkeson, Daniel J. Wallace, Michael H. Weisman, Gerald B. Appel
New England Journal of Medicine. 20051,131 CitationsOPEN ACCESS
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
Gerald B. Appel, Gabriel Contreras, Mary Anne Dooley, Ellen M. Ginzler, David Isenberg, David Jayne, LI Leishi, Eduardo Mysler, Jorge Sa[Combining Acute Accent]nchez-Guerrero, Neil Solomons, David Wofsy
Journal of the American Society of Nephrology. 20091,122 CitationsOPEN ACCESS
Related on ScholarIQ
NewYork–Presbyterian Hospital
Institution
The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited
Paper
The classification of glomerulonephritis in systemic lupus erythematosus revisited
Paper
Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
Paper
Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis
Paper
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
Paper